Plato Investment Management LTD Neurocrine Biosciences Inc Transaction History
Plato Investment Management LTD
- $1.36 Trillion
- Q4 2024
A detailed history of Plato Investment Management LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Plato Investment Management LTD holds 10,844 shares of NBIX stock, worth $1.25 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
10,844
Previous 10,973
1.18%
Holding current value
$1.25 Million
Previous $1.26 Billion
17.62%
% of portfolio
0.11%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
95.2MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.64 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.17 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$565 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$349 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$293 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...